Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1975 Oct 25;4(5990):195–197. doi: 10.1136/bmj.4.5990.195

Enhanced antiplasmin activity in acute renal failure.

A Kanfer, A Vandewalle, M Beaufils, F Delarue, J D Sraer
PMCID: PMC1674993  PMID: 1191995

Abstract

Plasmatic slow plasmin-inhibitor activity was assessed in 20 patients with acute renal failure and 12 controls with the fibrin plate method. The area of fibrinolysis was 250-5 +/- 5 mm2 in the patients and 289 +/- 6mm2 in the controls (P less than 0.001) and was negatively correlated with antiplasmin activity. Thirteen patients had areas of lysis equal to or inferior to the minimal lysis observed in the controls. No correlation was found between antiplasmin activity and serum fibrin-fibrinogen related antigen titres, the presence or absence of disseminated intravascular coagulation, or the causative disease.

Full text

PDF
195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  2. Ben-Ishay Z. Contributions to renal pathology through the use of the electron microscope: glomerular changes. Isr J Med Sci. 1967 Jan-Feb;3(1):191–197. [PubMed] [Google Scholar]
  3. Bergstein J. M., Michael A. F., Jr Cortical fibrinolytic activity in normal and diseased human kidneys. J Lab Clin Med. 1972 May;79(5):701–709. [PubMed] [Google Scholar]
  4. Bonnar J., McNicol G. P., Douglas A. S. Fibrinolytic enzyme system and pregnancy. Br Med J. 1969 Aug 16;3(5667):387–389. doi: 10.1136/bmj.3.5667.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Charytan C., Purtilo D. Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med. 1969 May 15;280(20):1102–1104. doi: 10.1056/NEJM196905152802006. [DOI] [PubMed] [Google Scholar]
  6. Clarkson A. R., MacDonald M. K., Fuster V., Cash J. D., Robson J. S. Glomerular coagulation in acute ischaemic renal failure. Q J Med. 1970 Oct;39(156):585–599. [PubMed] [Google Scholar]
  7. Colman R. W., Robboy S. J., Minna J. D. Disseminated intravascular coagulation (DIC): an approach. Am J Med. 1972 May;52(5):679–689. doi: 10.1016/0002-9343(72)90058-7. [DOI] [PubMed] [Google Scholar]
  8. Earley L. E. Pathogenesis of oliguric acute renal failure. N Engl J Med. 1970 Jun 11;282(24):1370–1371. doi: 10.1056/NEJM197006112822409. [DOI] [PubMed] [Google Scholar]
  9. Ekelund H., Hedner U., Astedt B. Fibrinolysis in human foetuses. Acta Paediatr Scand. 1970 Jul;59(4):369–376. doi: 10.1111/j.1651-2227.1970.tb15530.x. [DOI] [PubMed] [Google Scholar]
  10. Garvey M. B., Black J. M. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle. J Clin Pathol. 1972 Aug;25(8):680–682. doi: 10.1136/jcp.25.8.680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Haanen C., Holdrinet A., Wijdeveld P. Intravascular clotting and acute renal failure. Scand J Haematol Suppl. 1971;13:337–343. doi: 10.1111/j.1600-0609.1971.tb02033.x. [DOI] [PubMed] [Google Scholar]
  12. Hedner U., Nilsson M. Clinical experience with determination of fibrinogen degradation products. Acta Med Scand. 1971 Jun;189(6):471–477. doi: 10.1111/j.0954-6820.1971.tb04407.x. [DOI] [PubMed] [Google Scholar]
  13. Howie P. W., Mallinson A. C., Prentice C. R., Horne C. H., McNicol G. P. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet. 1970 Dec 26;2(7687):1329–1332. doi: 10.1016/s0140-6736(70)92358-5. [DOI] [PubMed] [Google Scholar]
  14. Kleinknecht D., Kanfer A., Josso F. Intravascular coagulation and heparin therapy in acute renal failure: a reappraisal. Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):695–700. [PubMed] [Google Scholar]
  15. NAEYE R. L. Thrombotic disorders with increased levels of antiplasmin and antiplasminogen. N Engl J Med. 1961 Nov 2;265:867–871. doi: 10.1056/NEJM196111022651801. [DOI] [PubMed] [Google Scholar]
  16. NORMAN P. S. Studies of the plasmin system. II. Inhibition of plasmin by serum or plasma. J Exp Med. 1958 Jul 1;108(1):53–68. doi: 10.1084/jem.108.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Oken D. E. Nosologic considerations in the nomenclature of acute renal failure. Nephron. 1971;8(6):505–510. doi: 10.1159/000179956. [DOI] [PubMed] [Google Scholar]
  18. Wardle E. N. Fibrin in renal disease: functional considerations. Clin Nephrol. 1974;2(3):85–92. [PubMed] [Google Scholar]
  19. Wardle E. N. Fibrinogen catabolism studies in patients with renal disease. Q J Med. 1973 Jan;42(165):205–219. [PubMed] [Google Scholar]
  20. Wardle E. N., Wright N. A. Intravascular coagulation and glycerin hemoglobinuric acute renal failure. Arch Pathol. 1973 Apr;95(4):271–275. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES